Research Atlas · source screening

Micafungin

An attributable first-pass index of PubMed records whose titles name this governed identity. Records are sorted by publication date, not by evidence strength. Inclusion does not establish efficacy, safety, or a clinical indication.

Title-search results

711

Shown with stable PMIDs

25

Search recorded

2026-09-26

Source: NCBI PubMed / MEDLINE · exact query: "Micafungin"[Title] · up to 25 recent title matches per identity. Each result links to its PubMed record.

1. Micafungin microevolution in Candida auris reveals resistance development without in vivo fitness compromise.

   Virulence · 2026 Dec · PMID 42051239 · DOI 10.1080/21505594.2026.2664993

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

2. Electronic-nomogram-guided micafungin dosing regimen in critically ill patients: A population pharmacokinetic study.

   Int J Antimicrob Agents · 2026 Aug 17 · PMID 42607967 · DOI 10.1016/j.ijantimicag.2026.107970

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

3. In Vitro Activity and In Vivo Efficacy in a Murine Model of Rezafungin, Anidulafungin, Caspofungin, and Micafungin Against the Fifth Clade of Candida (Candidozyma) auris.

   J Fungi (Basel) · 2026 Jul 24 · PMID 42646079 · DOI 10.3390/jof12080552

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

4. Clinical Outcomes of Micafungin and Anidulafungin in Candidozyma auris (Formerly Candida auris) Candidemia: A Propensity Score-Matched Retrospective Cohort Study.

   J Fungi (Basel) · 2026 Jul 22 · PMID 42506298 · DOI 10.3390/jof12070537

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

5. Correction: Comparative real-world safety profiles of caspofungin, micafungin, and anidulafungin: a disproportionality analysis based on FAERS and VigiAccess databases.

   Front Pharmacol · 2026 · PMID 42524035 · DOI 10.3389/fphar.2026.1916009

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

6. Micafungin Sequestration and Late Release During Continuous Renal Replacement Therapy with Polyacrylonitrile- and Polysulfone-Derived Filters.

   Infect Dis Ther · 2026 Jul · PMID 42236641 · DOI 10.1007/s40121-026-01367-8

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

7. Micafungin exposure drives multidrug resistance in Clavispora lusitaniae.

   bioRxiv · 2026 Jun 30 · PMID 42427506 · DOI 10.64898/2026.06.29.735437

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

8. Comparative real-world safety profiles of caspofungin, micafungin, and anidulafungin: a disproportionality analysis based on FAERS and VigiAccess databases.

   Front Pharmacol · 2026 · PMID 42394979 · DOI 10.3389/fphar.2026.1840717

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

9. High and Sustained Release of the Novel Echinocandin Rezafungin From Bone Cement: An In Vitro Comparison With Liposomal Amphotericin B and Micafungin.

   J Arthroplasty · 2026 May 28 · PMID 42208696 · DOI 10.1016/j.arth.2026.05.047

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

10. Impact of a Pharmacy-Driven (1,3)-β-D-Glucan Algorithm on Micafungin Duration of Therapy in the ICU.

    J Pharm Technol · 2026 May 23 · PMID 42186584 · DOI 10.1177/87551225261446911

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

11. Successful treatment of a fluconazole low-susceptibility Kodamaea ohmeri bloodstream infection with micafungin: A case report and literature review.

    IDCases · 2026 · PMID 41846823 · DOI 10.1016/j.idcr.2026.e02544

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

12. Twice-Weekly Micafungin as Antifungal Prophylaxis in Children Undergoing Hematopoietic Stem Cell Transplantation.

    Pediatr Transplant · 2026 Mar · PMID 41820822 · DOI 10.1111/petr.70296

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

13. Successful treatment with rezafungin after micafungin for relapsing Rasamsonia argillacea species complex pneumonia in a patient with bronchiectasis: A case report.

    Int J Infect Dis · 2026 Mar · PMID 41435983 · DOI 10.1016/j.ijid.2025.108336

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

14. Micafungin-induced hemolytic anemia: a case report and investigation of anti-micafungin antibody prevalence.

    Int J Hematol · 2026 Feb · PMID 41604063 · DOI 10.1007/s12185-026-04161-x

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

15. Identifying metabolic bottlenecks for micafungin precursor production via untargeted regulatory perturbation.

    Biotechnol Biofuels Bioprod · 2026 Jan 14 · PMID 41535937 · DOI 10.1186/s13068-026-02737-7

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

16. Micafungin-induced rhabdomyolysis and myocardial injury: a case report.

    Front Med (Lausanne) · 2025 · PMID 41426586 · DOI 10.3389/fmed.2025.1708395

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

17. SIP-SRS Imaging of Cell Wall Synthesis Identifies a Synergy between Micafungin and Amphotericin B.

    Adv Sci (Weinh) · 2025 Dec · PMID 41117037 · DOI 10.1002/advs.202507331

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

18. From AUC/MIC to AUCss and Cmin: Optimizing Micafungin Therapy in the Critically Ill through Model-Informed Precision Dosing.

    AAPS J · 2025 Nov 11 · PMID 41219680 · DOI 10.1208/s12248-025-01173-z

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

19. Severe Saprochaete capitata fungemia presenting as micafungin breakthrough hepatosplenic lesions in an immunocompromised patient: case report.

    ASM Case Rep · 2025 Nov · PMID 41244286 · DOI 10.1128/asmcr.00071-25

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

20. Successful combination therapy with voriconazole and micafungin for voriconazole-resistant Scedosporium dehoogii pulmonary infection: A case report with in vitro analysis.

    J Infect Chemother · 2025 Nov · PMID 41106552 · DOI 10.1016/j.jiac.2025.102832

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

21. Optimizing Micafungin Dosing in Patients with Critically Ill Candidemia and Trends of Candida Species Causing Bloodstream Infections in a Tertiary Hospital in Thailand: A Monte Carlo Simulation Approach.

    Drug Des Devel Ther · 2025 · PMID 41164403 · DOI 10.2147/DDDT.S549066

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

22. Ultrastructural and Immunohistochemical Study on the Nephrotoxicity Following Intravitreal Administration of the Antifungal Agents Voriconazole and Micafungin in New Zealand White Rabbits.

    Int J Mol Sci · 2025 Oct 17 · PMID 41155421 · DOI 10.3390/ijms262010129

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

23. Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin.

    J Clin Med · 2025 Oct 16 · PMID 41156164 · DOI 10.3390/jcm14207294

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

24. The mechanism of action of micafungin against pteropine orthoreovirus infection in the human A549 cell line.

    Arch Virol · 2025 Aug 25 · PMID 40855388 · DOI 10.1007/s00705-025-06369-4

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

25. Comparative study of liposomal amphotericin B, posaconazole, and micafungin for primary antifungal prophylaxis in pediatric patients with acute leukemia.

    J Cancer Res Clin Oncol · 2025 Aug 23 · PMID 40848057 · DOI 10.1007/s00432-025-06289-5

    Source metadata only · evidence grade unassigned · scientific conclusions pending review